Kelevo 400 µg tablets for dogs and cats
Kelevo 400 µg tablets for dogs and cats
Authorised
- Levothyroxine sodium
Product identification
Medicine name:
Kelevo 400 µg tablets for dogs and cats
Kelevo 400 µg tabletes suņiem un kaķiem
Active substance:
- Levothyroxine sodium
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levothyroxine sodium400.00/microgram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
- aniMedica Herstellungs GmbH
- Industrial Veterinaria S.A.
- Lelypharma B.V.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/DCP/21/0033
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0349/002
Concerned member states:
-
Austria
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 20/03/2024
Latvian (PDF)
Published on: 25/03/2024
How useful was this page?:
